Stay updated with breaking news from Nasdaq Obsv. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com initiated coverage on shares of ObsEva (NASDAQ:OBSV – Get Rating) in a research report sent to investors on Saturday. The firm issued a hold rating on the stock. ObsEva Stock Down 21.4 % Shares of OBSV opened at $0.08 on Friday. The firm has a market cap of $6.24 million, a PE ratio of […]
StockNews.com assumed coverage on shares of ObsEva (NASDAQ:OBSV – Get Rating) in a note issued to investors on Wednesday. The brokerage set a “hold” rating on the stock. Other equities analysts have also recently issued research reports about the company. Canaccord Genuity Group cut ObsEva from a “buy” rating to a “hold” rating and decreased […]
$7.6 million annual savings expected via reduction-in-force currently underway$6.2 million savings expected from assignment of legacy linzagolix program...
ObsEva (NASDAQ: OBSV) has recently received a number of price target changes and ratings updates: 6/5/2022 – ObsEva was upgraded by analysts at StockNews.com from a “sell” rating to a “hold” rating. 6/3/2022 – ObsEva is now covered by analysts at Cantor Fitzgerald. They set an “overweight” rating and a $6.00 price target on the […]
ObsEva (NASDAQ:OBSV – Get Rating) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Thursday, Zacks.com reports. The brokerage currently has a $1.75 price target on the stock. Zacks Investment Research‘s price target would indicate a potential upside of 4.79% from the […]